Autonomix Medical, Inc. vs Eli Lilly & Co.
AMIX vs LLY — side-by-side comparison from reported financials. AMIX leads 0, LLY leads 5 of 5 comparable metrics.
Autonomix Medical, Inc.
AMIX · Healthcare
$2.87-2.05%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 255.73+0.33%Solid
| Metric | AMIX | LLY |
|---|---|---|
| Price | $2.87 | $1 255.73 |
| Market cap | $10.0M | $1.12T |
| Revenue (TTM) | — | $79.7B |
| Revenue growth | — | +31.7% |
| Net margin | — | 33.5% |
| Free cash flow | -$13.2M | $18.2B |
| Net cash (debt) | — | ($35.2B) |
| 1-year price return | -87.7% | +53.3% |
| P/E | — | 43.8 |
| P/E vs own history (cheap-side %) | — | 79% |
| Dividend yield | — | 0.49% |
| Return on equity | -268% | 93% |
| Altman Z-score | -24.77 | 7.49 |
| CV checks passed | 1 of 8 | 11 of 8 |
| Employees | 11 | 50,000 |
Full résumé-style profiles: AMIX CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.